ERBB2 and neoplasm: The expression of immune checkpoint molecules pd1 and pdl2 was also significantly upregulated following Flagrp170-Her/neu vaccination (Figure 4H), further supporting the enhanced activity of Flagrp170 in immunologically reprogramming the tumor microenvironment.